Pages with the fewest revisions

Jump to navigation Jump to search

Showing below up to 50 results in range #57,751 to #57,800.

View ( | ) (20 | 50 | 100 | 250 | 500)

  1. Neuroendocrine tumors epidemiology and demographics (4 revisions)
  2. Neuroendocrine tumors physical examination (4 revisions)
  3. Neuroendocrine tumors risk factors (4 revisions)
  4. Neuroendocrine tumors screening (4 revisions)
  5. Neuroendocrine tumors ultrasound (4 revisions)
  6. Neurofibroma diagnostic study of choice (4 revisions)
  7. Neurofibromatosis type 1 MRI (4 revisions)
  8. Neurofibromatosis type 1 laboratory findings (4 revisions)
  9. Neurofibromatosis type 1 medical therapy (4 revisions)
  10. Neurofibromatosis type 1 pathophysiology (4 revisions)
  11. Neurofibromatosis type 1 screening (4 revisions)
  12. Neurofibromatosis type 1 surgery (4 revisions)
  13. Neurofibromin 1 (4 revisions)
  14. Neurologic complications of cardiovascular diseases (4 revisions)
  15. Neuromedin B (4 revisions)
  16. Neuromedin U (4 revisions)
  17. Neuropeptide FF receptor 2 (4 revisions)
  18. Neuropeptide Y receptor Y1 (4 revisions)
  19. Neuropeptide Y receptor Y2 (4 revisions)
  20. Neuropeptide Y receptor Y5 (4 revisions)
  21. Neuropeptides B/W receptor 1 (4 revisions)
  22. Neuropeptides B/W receptor 2 (4 revisions)
  23. Neurosyphilis Epidemiology and Demographics (4 revisions)
  24. Neurotensin receptor 1 (4 revisions)
  25. Neurotrophin-3 (4 revisions)
  26. Neutropenia CT (4 revisions)
  27. Neutropenia MRI (4 revisions)
  28. Neutropenia chest x ray (4 revisions)
  29. Neutropenia other diagnostic studies (4 revisions)
  30. Neutropenia other imaging findings (4 revisions)
  31. Neutropenia secondary prevention (4 revisions)
  32. Neutropenia surgery (4 revisions)
  33. Neutropenia ultrasound (4 revisions)
  34. Neutrophil cytosolic factor 4 (4 revisions)
  35. Nevus of Ota (4 revisions)
  36. Nexterone injection indications and usage (4 revisions)
  37. Niacin/lovastatin (4 revisions)
  38. Niceritrol (4 revisions)
  39. Niclosamide dosage (4 revisions)
  40. Nicomorphine (4 revisions)
  41. Night terror (patient information) (4 revisions)
  42. Nipah virus encephalitis case study one (4 revisions)
  43. Nipah virus encephalitis cost-effectiveness of therapy (4 revisions)
  44. Nipah virus encephalitis future or investigational therapies (4 revisions)
  45. Nipah virus encephalitis laboratory findings (4 revisions)
  46. Nipah virus encephalitis natural history, complications and prognosis (4 revisions)
  47. Nipah virus encephalitis other diagnostic studies (4 revisions)
  48. Nipah virus encephalitis primary prevention (4 revisions)
  49. Nipah virus encephalitis risk factors (4 revisions)
  50. No-reflow phenomenon coronary angiography (4 revisions)

View ( | ) (20 | 50 | 100 | 250 | 500)

Retrieved from "https://www.wikidoc.org/index.php/Special:FewestRevisions"